Fortrea Holdings
FTRE
20.56
-0.22
-1.06%
Fortrea Holdings
US · FTRE
#2796 by market cap
Listed 2023
20.56
-0.22
-1.06%
Live - 5344 symbols - heartbeat 90s ago
· 2026-10-08 04:52
Pre-market
20.93
+1.81%
After-hours
20.56
0.00%
- Market cap
- 1.96B
- P/E (TTM)i
- -24.77
- P/Bi
- 3.73
- EPSi
- -10.81
- Div yieldi
- 0.00%
- 52W posi
- 80%
Reader sentiment
Are you bullish or bearish on FTRE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.79, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 6 years
Latest year +1.00% YoY
Margins
- Gross margin
- 18.50%
- Operating margin
- -1.12%
- Net margin
- -36.21%
Key ratios & quality
- Enterprise valuei
- 2.84B
- Altman Z-Scorei
- 0.79
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 2.58B | 3.06B | 2.84B | 2.84B | 2.70B | 2.72B |
| Gross profit | 489.10M | 604.40M | 724.40M | 590.60M | 534.20M | 503.80M |
| Selling & admin expenses | 267.60M | 303.10M | 416.10M | 448.10M | 560.70M | 456.40M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 102.50M | 135.00M | 222.80M | 53.20M | -111.80M | -30.60M |
| Pretax profit | -332.20M | 136.40M | 187.00M | -30.50M | -275.00M | -983.00M |
| Tax | 27.00M | 38.40M | 41.10M | 1.20M | -3.50M | 3.20M |
| Net profit | -359.20M | 98.00M | 186.20M | -25.20M | -328.50M | -986.20M |
| Basic EPS | -4 | 1 | 2 | 0 | -4 | -11 |
| Diluted EPS | -4.06 | 1.11 | 2.11 | -0.29 | -3.67 | -10.81 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 651.30M | 710.30M | 701.30M | 660.50M | 636.50M | 678.20M |
| Gross profit | 116.50M | 133.50M | 122.70M | 131.10M | 123.60M | 139.20M |
| Selling & admin expenses | 121.80M | 124.80M | 106.80M | 103.00M | 100.50M | 102.10M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -24.80M | -10.90M | -3.70M | 8.80M | 3.30M | 17.50M |
| Pretax profit | -548.00M | -370.70M | -28.70M | -35.60M | -12.30M | -1.20M |
| Tax | 14.90M | 4.20M | -12.80M | -3.10M | 11.30M | 12.00M |
| Net profit | -562.90M | -374.90M | -15.90M | -32.50M | -23.60M | -13.20M |
| Basic EPS | -6 | -4 | 0 | 0 | 0 | 0 |
| Diluted EPS | -6.25 | -4.14 | -0.17 | -0.35 | -0.25 | -0.14 |
Balance sheet
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total current assets | -- | 1.12B | 1.25B | 1.25B | 948.20M | 897.20M |
| Cash & ST investments | -- | 94.60M | 112.00M | 108.60M | 118.50M | 174.60M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | -- | 4.37B | 4.29B | 4.33B | 3.58B | 2.72B |
| Total current liabilities | -- | 826.70M | 699.00M | 778.40M | 949.50M | 913.30M |
| Short-term debt | -- | 24.00M | 23.30M | 43.30M | 88.20M | 14.00M |
| Long-term debt | -- | -- | -- | 1.57B | 1.05B | 1.05B |
| Total liabilities | -- | 1,108,100,000.00 | 945,300,000.00 | 2,618,500,000.00 | 2,216,800,000.00 | 2,152,200,000.00 |
| Total equity | -- | 3.26B | 3.34B | 1.71B | 1.36B | 563.50M |
| Retained earnings | -- | -- | 0 | -68.50M | -397.00M | -1.38B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 970.30M | 960.00M | 918.50M | 897.20M | 881.50M | 923.60M |
| Cash & ST investments | 101.60M | 81.20M | 131.30M | 174.60M | 147.50M | 168.60M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 3.12B | 2.84B | 2.74B | 2.72B | 2.68B | 2.71B |
| Total current liabilities | 999.10M | 942.30M | 914.40M | 913.30M | 929.10M | 963.70M |
| Short-term debt | 177.30M | 87.20M | 83.70M | 14.00M | 19.70M | 26.00M |
| Long-term debt | 1.05B | 1.10B | 1.05B | 1.05B | 1.04B | 1.04B |
| Total liabilities | 2,262,300,000.00 | 2,245,900,000.00 | 2,161,300,000.00 | 2,152,200,000.00 | 2,157,500,000.00 | 2,190,700,000.00 |
| Total equity | 858.80M | 589.20M | 580.80M | 563.50M | 525.90M | 524.20M |
| Retained earnings | -959.90M | -1.33B | -1.35B | -1.38B | -1.41B | -1.42B |
Cash flow
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | 200.90M | 169.80M | 82.70M | 168.40M | 262.80M | 113.50M |
| Depreciation & amortization | 119.00M | 166.30M | 93.60M | 98.00M | 86.90M | 78.00M |
| Free cash flow | 176.90M | 143.30M | 28.30M | 128.10M | 237.30M | 88.30M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 80.30M | 94.60M | 110.40M | 108.60M | 118.50M | 174.60M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -124.20M | 21.80M | 86.80M | 129.10M | -17.00M | 28.90M |
| Depreciation & amortization | 19.50M | 19.60M | 19.60M | 19.30M | 19.80M | 19.60M |
| Free cash flow | -127.10M | 14.30M | 79.50M | 121.60M | -25.00M | 19.90M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 101.60M | 81.20M | 131.30M | 174.60M | 147.50M | 168.60M |
Returns & efficiency
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROE %i | -- | 3.01 | 1.77 | -0.13 | -21.19 | -102.41 |
| ROA %i | -- | 2.24 | 1.35 | -0.08 | -8.28 | -31.33 |
| ROIC %i | -- | 2.94 | 5.63 | 1.52 | -6.90 | -43.11 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -23.22 |
| EBIT margin %i | 3.97 | 4.42 | 6.18 | 2.28 | -5.61 | -32.74 |
| FCF / sales %i | 6.86 | 4.69 | 1.07 | 4.09 | 8.80 | 3.24 |
| Current ratioi | -- | 1.35 | 1.78 | 1.61 | 1.00 | 0.98 |
| Quick ratioi | -- | 1.26 | 1.66 | 1.44 | 0.86 | 0.87 |
| Debt / assetsi | -- | 1.77 | 1.48 | 38.59 | 33.49 | 41.09 |
| LT debt / equityi | -- | 1.63 | 1.20 | 95.02 | 81.50 | 195.56 |
| Interest coveragei | -- | -- | 1.44 | 1.02 | -1.22 | -9.75 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 3.28 | -4.10 | -1.35 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -10.20 | 18.31 | 46.13 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -64.50 | -100.17 | -96.92 | -102.41 | -64.55 | -15.30 |
| ROA %i | -21.47 | -32.09 | -31.69 | -31.33 | -15.40 | -3.07 |
| ROIC %i | -25.88 | -42.54 | -42.08 | -43.11 | -18.94 | -2.00 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -23.66 | -34.37 | -33.78 | -32.74 | -13.26 | 0.24 |
| FCF / sales %i | 5.40 | -- | -- | 3.24 | 7.03 | 7.32 |
| Current ratioi | 0.97 | 1.02 | 1.00 | 0.98 | 0.95 | 0.96 |
| Quick ratioi | 0.83 | 0.87 | 0.87 | 0.87 | 0.83 | 0.85 |
| Debt / assetsi | 41.21 | 43.77 | 43.30 | 41.09 | 41.66 | 41.16 |
| LT debt / equityi | 129.13 | 195.82 | 190.01 | 195.56 | 208.84 | 208.22 |
| Interest coveragei | -5.68 | -10.45 | -10.35 | -9.75 | -4.07 | 0.08 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Clinical services100.00%
Quote time 2026-10-08 04:52:21 · For reference only, not investment advice and not tailored to your situation.